使用超文本标记语言 (HTML) 和JavaScript自动化癌症综合报告
Aaron Duan1, Kevin Guo1, Huazhang Guo2
1Clayton High School, Clayton, MO, US.
American journal of clinical pathology
|January 1, 2025
概括
这项研究使用HTML/JavaScript开发了低成本,电子的美国病理学家学院 (CAP) 癌症协议. 这种自动化大大减少了病理学家的报告时间,特别是在资源有限的环境中.
科学领域:
- 病理学信息学 病理学信息学
- 医疗信息学医学信息学
- 数字病理学数字病理学
背景情况:
- 美国病理学家学院 (CAP) 癌症协议对于标准化癌症综合报告至关重要.
- 当前的电子格式通常是昂贵的或需要大量的技术资源.
- 资源有限的实验室经常使用易出错的可打印协议,需要手动输入和编辑数据.
研究的目的:
- 开发一个低成本,灵活和可访问的电子版本的CAP癌症协议.
- 为了自动化癌症综合报告病理学实验室的财务和技术限制.
主要方法:
- 使用HTML创建动态数据输入表格,并为每个可打印的CAP癌症协议嵌入JavaScript.
- 利用一个伴随的JavaScript程序在Web浏览器中自动生成综合报告.
- 使病理学家能够直接将特定病例信息输入到电子表格中.
主要成果:
- 成功地将常用的CAP癌症协议实现为电子HTML/JavaScript格式.
- 与手动方法相比,在病理学家报告方面至少节省了50%的时间.
- 证明了自动化综合癌症报告的可行性.
结论:
- 开发的HTML/JavaScript CAP癌症协议为现有的电子解决方案提供了具有成本效益和灵活性的替代方案.
- 这种方法对资源有限的病理学家尤其有益.
- 该方法可以扩展到实施国际和非英语癌症协议.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Types of Reports I: Hands-off Report
882
A hand-off report, also known as a change-of-shift report, is a crucial nursing process that ensures the smooth transition of patient care responsibilities between nursing staff.
Following are the key components and categories of hand-off reports:
Purpose and Process:
Following are the key components and categories of hand-off reports:
Purpose and Process:
882
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


